Sika Interplant Systems Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Sika Interplant Systems hat ein Gesamteigenkapital von ₹1.0B und eine Gesamtverschuldung von ₹0.0, wodurch sich der Verschuldungsgrad auf 0% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen ₹1.2B bzw. ₹186.1M. Sika Interplant Systems Das EBIT des Unternehmens beträgt ₹244.0M, so dass der Zinsdeckungsgrad 119.2 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von ₹244.9M.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

₹0

Verschuldung

Zinsdeckungsgrad	93x
Bargeld	₹244.94m
Eigenkapital	₹1.03b
Gesamtverbindlichkeiten	₹186.09m
Gesamtvermögen	₹1.22b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 523606Die kurzfristigen Aktiva des Unternehmens (₹448.5M) übersteigen seine kurzfristigen Passiva (₹152.5M).

Langfristige Verbindlichkeiten: 523606Die kurzfristigen Vermögenswerte des Unternehmens (₹448.5M) übersteigen seine langfristigen Verbindlichkeiten (₹33.6M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 523606 ist schuldenfrei.

Schulden abbauen: 523606 hat keine Schulden im Vergleich zu vor 5 Jahren, als das Verhältnis von Schulden zu Eigenkapital 2.6% betrug.

Schuldendeckung: 523606 hat keine Schulden und muss daher nicht durch den operativen Cashflow gedeckt werden.

Zinsdeckung: 523606 hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.

Sika Interplant Systems Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Investor sentiment improves as stock rises 15%

Full year 2024 earnings released: EPS: ₹45.66 (vs ₹20.73 in FY 2023)

Investor sentiment improves as stock rises 21%

Sika Interplant Systems Limited to Report Fiscal Year 2024 Results on May 20, 2024

Investor sentiment improves as stock rises 18%

Investor sentiment deteriorates as stock falls 22%

Third quarter 2024 earnings released: EPS: ₹11.15 (vs ₹5.19 in 3Q 2023)

Sika Interplant Systems Limited to Report Q3, 2024 Results on Feb 13, 2024

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 20%

Second quarter 2024 earnings released: EPS: ₹11.83 (vs ₹4.99 in 2Q 2023)

Sika Interplant Systems Limited to Report Q2, 2024 Results on Nov 08, 2023

Investor sentiment improves as stock rises 19%

Sika Interplant Systems Limited Approves Dividend for the Financial Year Ended March 31, 2023

Upcoming dividend of ₹4.00 per share at 0.4% yield

Investor sentiment improves as stock rises 20%

New major risk - Share price stability

Sika Interplant Systems Limited, Annual General Meeting, Sep 29, 2023

First quarter 2024 earnings released: EPS: ₹8.42 (vs ₹5.24 in 1Q 2023)

Investor sentiment improves as stock rises 19%

Sika Interplant Systems Limited to Report Q1, 2024 Results on Aug 09, 2023

Investor sentiment improves as stock rises 21%

Full year 2023 earnings released: EPS: ₹20.73 (vs ₹39.01 in FY 2022)

Sika Interplant Systems Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023

Sika Interplant Systems Limited to Report Q4, 2023 Results on May 17, 2023

Investor sentiment deteriorates as stock falls 16%

Third quarter 2023 earnings released: EPS: ₹5.19 (vs ₹5.31 in 3Q 2022)

Sika Interplant Systems Limited to Report Q3, 2023 Results on Feb 10, 2023

Second quarter 2023 earnings released: EPS: ₹4.99 (vs ₹16.49 in 2Q 2022)

Sika Interplant Systems Limited to Report Q2, 2023 Results on Nov 14, 2022

Sika Interplant Systems Announces Appointment of Mr. Garimella Bhaskar Venkata Satya as an Non-Executive- Independent Director

Sika Interplant Systems Limited Appoints Barun Pandey as Company Secretary

Now 20% undervalued

Sika Interplant Systems Limited Recommends Dividend

Upcoming dividend of ₹4.00 per share

Full year 2022 earnings released: EPS: ₹39.01 (vs ₹27.93 in FY 2021)

Investor sentiment deteriorated over the past week

Sika Interplant Systems Limited, Annual General Meeting, Sep 28, 2022

Now 20% undervalued

Sika Interplant Systems Limited to Report Q1, 2023 Results on Aug 12, 2022

Sika Interplant Systems Limited Appoints Sathish K.S as Chief Financial Officer

Now 21% undervalued after recent price drop

Investor sentiment improved over the past week

Now 22% undervalued

Now 22% undervalued after recent price drop

Sika Interplant Systems Limited Recommends Dividend for the Financial Year Ended 31 March 2022

Sika Interplant Systems Limited to Report Fiscal Year 2022 Results on May 09, 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₹4.00 per share

First quarter 2022 earnings released: EPS ₹9.62 (vs ₹7.13 in 1Q 2021)

Full year 2021 earnings released

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹5.96 (vs ₹2.29 in 3Q 2020)

Investor sentiment improved over the past week

New 90-day high: ₹333

Sika Interplant Systems Limited to Report Q3, 2021 Results on Feb 12, 2021

Investor sentiment improved over the past week

New 90-day high: ₹282

Sika Interplant Systems Limited to Report Q2, 2021 Results on Nov 11, 2020

First quarter earnings released

Sika Interplant Systems Limited to Report Q1, 2021 Results on Sep 15, 2020

New 90-day high - ₹198

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen